or Try an Advanced Search...

    ETF Components for CGIE - Capital Group International Equity ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVO C -0.47 4.22
    TSM C 1.76 2.00

    Represented by ETF Holdings

    Keywords: Anti Diabetic Drugs Biopharmaceutical Diabetes Diabetes Care Endocrine System Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hormone Therapy Hormones Inflammation Insulin Integrated Circuits Life Sciences Obesity On Semiconductor Peptide Hormones Pharmaceutical Products Pharmaceuticals Segment
    Industries: Biotechnology Semiconductors

    Recent News for Capital Group International Equity ETF & its Holdings

    Date Stock Title
    May 8 TSM TSMC: Charting A Path To $185
    May 8 TSM Every household should be forced to have a smart meter, says British Gas boss
    May 8 TSM US official says Chinese seizure of TSMC in Taiwan would be 'absolutely devastating'
    May 8 TSM US chip manufacturing capacity projected to triple by 2032, fueled by CHIPS Act: Industry leader
    May 8 NVO Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
    May 8 TSM US chip output to see massive growth by 2032: Industry leader
    May 7 TSM Intel's New Venture in Japan: Pioneering Automation in Chip Manufacturing by 2028
    May 7 NVO 13 Best Stocks That Will Always Grow
    May 7 TSM 12 Best Investments for Beginners in 2024
    May 7 TSM Latest Apple event is on tap, along with AI chip rumors
    May 7 TSM Apple working on AI chips for data centers, WSJ reports
    May 7 TSM Apple Is Developing AI Chips for Data Centers, Seeking Edge in Arms Race
    May 6 NVO Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
    May 6 TSM Why Arista Networks, Advanced Micro Devices, and Arm Holdings Fell in April
    May 6 NVO Investors Pile Into Amgen in Search of Next Obesity Drug Payout
    May 6 NVO Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
    May 6 TSM Taiwan Semiconductor: Solid HPC Revenue, Partially Offset By Smartphone Seasonality (Downgrade)
    May 6 NVO 'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem
    May 4 NVO Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
    May 4 NVO Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
    The fund invests primarily in common stocks of issuers outside of the United States that the investment adviser believes have the potential for growth, many of which have the potential to pay dividends. Under normal market conditions, the fund will invest at least 80% of its net assets in equity securities, and at least 80% of its net assets in securities outside the United States. The fund is non-diversified.
    Stock Fund Dividend Financial Market Qualified Institutional Buyer
    Back to the Main CGIE Page...